BLU-945 is an investigational small molecule compound being researched as an EGFR inhibitor. It is a pharmaceutical raw material supplied for laboratory and research purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2660250-10-0
Zotepine
pharmaceutical raw material
Bisbentiamine
pharmaceutical raw material
Isoflurane
pharmaceutical raw material
(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino-d3)acetyl]amino]-3-[[(2-furanylcarbonyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; Excenel-d3; Excenel RTU-d3; U 64279A-d3; U 67279A-d3;
pharmaceutical raw material
N-[2-[(3S,4R)-3-fluoro-4-methoxypiperidin-1-yl]pyrimidin-4-yl]-8-[(2R,3S)-2-methyl-3-(methylsulfonylmethyl)azetidin-1-yl]-5-propan-2-ylisoquinolin-3-amine
LIMFPAAAIVQRRD-BCGVJQADSA-N
C[C@@H]1[C@H](CN1C2=C3C=NC(=CC3=C(C=C2)C(C)C)NC4=NC(=NC=C4)N5CC[C@H]([C@H](C5)F)OC)CS(=O)(=O)C